202 related articles for article (PubMed ID: 36065735)
1. VanG- and D-Ala-D-Ser-dependent peptidoglycan synthesis and vancomycin resistance in Clostridioides difficile.
Belitsky BR
Mol Microbiol; 2022 Nov; 118(5):526-540. PubMed ID: 36065735
[TBL] [Abstract][Full Text] [Related]
2. Histidine kinase-mediated cross-regulation of the vancomycin-resistance operon in Clostridioides difficile.
Belitsky BR
Mol Microbiol; 2024 Jun; 121(6):1182-1199. PubMed ID: 38690761
[TBL] [Abstract][Full Text] [Related]
3. Genomic and expression analysis of the vanG-like gene cluster of Clostridium difficile.
Peltier J; Courtin P; El Meouche I; Catel-Ferreira M; Chapot-Chartier MP; Lemée L; Pons JL
Microbiology (Reading); 2013 Jul; 159(Pt 7):1510-1520. PubMed ID: 23676437
[TBL] [Abstract][Full Text] [Related]
4. AsnB is responsible for peptidoglycan precursor amidation in
Ammam F; Patin D; Coullon H; Blanot D; Lambert T; Mengin-Lecreulx D; Candela T
Microbiology (Reading); 2020 Jun; 166(6):567-578. PubMed ID: 32375990
[No Abstract] [Full Text] [Related]
5. The vanG glycopeptide resistance operon from Enterococcus faecalis revisited.
Depardieu F; Bonora MG; Reynolds PE; Courvalin P
Mol Microbiol; 2003 Nov; 50(3):931-48. PubMed ID: 14617152
[TBL] [Abstract][Full Text] [Related]
6. DdlR, an essential transcriptional regulator of peptidoglycan biosynthesis in Clostridioides difficile.
Bouillaut L; Newton W; Sonenshein AL; Belitsky BR
Mol Microbiol; 2019 Nov; 112(5):1453-1470. PubMed ID: 31483905
[TBL] [Abstract][Full Text] [Related]
7. Competition between VanU(G) repressor and VanR(G) activator leads to rheostatic control of vanG vancomycin resistance operon expression.
Depardieu F; Mejean V; Courvalin P
PLoS Genet; 2015 Apr; 11(4):e1005170. PubMed ID: 25898178
[TBL] [Abstract][Full Text] [Related]
8. Structural and functional characterization of VanG D-Ala:D-Ser ligase associated with vancomycin resistance in Enterococcus faecalis.
Meziane-Cherif D; Saul FA; Haouz A; Courvalin P
J Biol Chem; 2012 Nov; 287(45):37583-92. PubMed ID: 22969085
[TBL] [Abstract][Full Text] [Related]
9. In vivo studies suggest that induction of VanS-dependent vancomycin resistance requires binding of the drug to D-Ala-D-Ala termini in the peptidoglycan cell wall.
Kwun MJ; Novotna G; Hesketh AR; Hill L; Hong HJ
Antimicrob Agents Chemother; 2013 Sep; 57(9):4470-80. PubMed ID: 23836175
[TBL] [Abstract][Full Text] [Related]
10. d-Alanyl-d-Alanine Ligase as a Broad-Host-Range Counterselection Marker in Vancomycin-Resistant Lactic Acid Bacteria.
Zhang S; Oh JH; Alexander LM; Özçam M; van Pijkeren JP
J Bacteriol; 2018 Jul; 200(13):. PubMed ID: 29686137
[TBL] [Abstract][Full Text] [Related]
11. Staphylococcus aureus VRSA-11B is a constitutive vancomycin-resistant mutant of vancomycin-dependent VRSA-11A.
Périchon B; Courvalin P
Antimicrob Agents Chemother; 2012 Sep; 56(9):4693-6. PubMed ID: 22710116
[TBL] [Abstract][Full Text] [Related]
12. VanA-type Staphylococcus aureus strain VRSA-7 is partially dependent on vancomycin for growth.
Moubareck C; Meziane-Cherif D; Courvalin P; Périchon B
Antimicrob Agents Chemother; 2009 Sep; 53(9):3657-63. PubMed ID: 19528271
[TBL] [Abstract][Full Text] [Related]
13. The functional vanGCd cluster of Clostridium difficile does not confer vancomycin resistance.
Ammam F; Meziane-Cherif D; Mengin-Lecreulx D; Blanot D; Patin D; Boneca IG; Courvalin P; Lambert T; Candela T
Mol Microbiol; 2013 Aug; 89(4):612-25. PubMed ID: 23782343
[TBL] [Abstract][Full Text] [Related]
14. Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediates and
Gargvanshi S; Vemula H; Gutheil WG
J Bacteriol; 2021 Jul; 203(16):e0023021. PubMed ID: 34060906
[TBL] [Abstract][Full Text] [Related]
15. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance.
Hong HJ; Hutchings MI; Neu JM; Wright GD; Paget MS; Buttner MJ
Mol Microbiol; 2004 May; 52(4):1107-21. PubMed ID: 15130128
[TBL] [Abstract][Full Text] [Related]
16. vanC cluster of vancomycin-resistant Enterococcus gallinarum BM4174.
Arias CA; Courvalin P; Reynolds PE
Antimicrob Agents Chemother; 2000 Jun; 44(6):1660-6. PubMed ID: 10817725
[TBL] [Abstract][Full Text] [Related]
17. Constitutive expression of the cryptic vanGCd operon promotes vancomycin resistance in Clostridioides difficile clinical isolates.
Shen WJ; Deshpande A; Hevener KE; Endres BT; Garey KW; Palmer KL; Hurdle JG
J Antimicrob Chemother; 2020 Apr; 75(4):859-867. PubMed ID: 31873741
[TBL] [Abstract][Full Text] [Related]
18. Crystallization and preliminary X-ray analysis of a D-Ala:D-Ser ligase associated with VanG-type vancomycin resistance.
Weber P; Meziane-Cherif D; Haouz A; Saul FA; Courvalin P
Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Oct; 65(Pt 10):1024-6. PubMed ID: 19851013
[TBL] [Abstract][Full Text] [Related]
19. New combinations of mutations in VanD-Type vancomycin-resistant Enterococcus faecium, Enterococcus faecalis, and Enterococcus avium strains.
Depardieu F; Foucault ML; Bell J; Dubouix A; Guibert M; Lavigne JP; Levast M; Courvalin P
Antimicrob Agents Chemother; 2009 May; 53(5):1952-63. PubMed ID: 19258279
[TBL] [Abstract][Full Text] [Related]
20. Vancomycin-dependent Enterococcus faecalis clinical isolates and revertant mutants.
Van Bambeke F; Chauvel M; Reynolds PE; Fraimow HS; Courvalin P
Antimicrob Agents Chemother; 1999 Jan; 43(1):41-7. PubMed ID: 9869563
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
